Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Felicita Andreotti, Antonino Buffon, Eliano Pio Navarese, Volker Schulze, Michalina Kolodziejczak, Marc Brouwer, Francesco Costa, Mariusz Kowalewski, Gianfranco Parati, Gregory Y. H. Lip, Malte Kelm, Marco Valgimigli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

229 Citazioni (Scopus)

Abstract

N/A
Lingua originaleEnglish
pagine (da-a)h1618-h1618
RivistaBMJ
Volume350
Stato di pubblicazionePubblicato - 2015

Keywords

  • Aspirin
  • Combined Modality Therapy
  • Coronary Artery Disease
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug-Eluting Stents
  • Hemorrhage
  • Humans
  • Models, Statistical
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Fingerprint Entra nei temi di ricerca di 'Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials'. Insieme formano una fingerprint unica.

Cita questo